A research programme by the Access to Medicine Foundation
  • In the media
  • Jayasree K. Iyer comments on what GSK’s new p...
Media - published on 05 Apr 2016

Jayasree K. Iyer comments on what GSK’s new patent policy means for the developing world

In the article, Jayasree K. Iyer comments on the effect of GSK’s move on other companies with bigger cancer portfolios.


Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.